ArticleJCEM case reports2023

Severe Insulin Resistance in a Patient Treated With Nivolumab and Brentuximab-Vedotin for Hodgkin Lymphoma.

Elif Tama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.